| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000088782.99568.CA |
| P698 | PubMed publication ID | 12925451 |
| P2093 | author name string | David A Kass | |
| Elliot R McVeigh | |||
| Gordon F Tomaselli | |||
| Christophe Leclercq | |||
| Richard S Tunin | |||
| David D Spragg | |||
| Deborah DiSilvestre | |||
| Owen P Faris | |||
| Morteza Loghmani | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 929-932 | |
| P577 | publication date | 2003-08-18 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Regional alterations in protein expression in the dyssynchronous failing heart | |
| P478 | volume | 108 |
| Q36345784 | A study of mechanical optimization strategy for cardiac resynchronization therapy based on an electromechanical model. |
| Q42559539 | Adrenergic and cholinergic plasticity in heart failure |
| Q47221649 | Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy |
| Q36174925 | Basic science of cardiac resynchronization therapy: molecular and electrophysiological mechanisms |
| Q43013630 | Beyond the measurement of QRS complex toward mechanical dyssynchrony: cardiac resynchronisation therapy in heart failure patients with a normal QRS duration |
| Q64091917 | Cardiac Resynchronisation Therapy and Cellular Bioenergetics: Effects Beyond Chamber Mechanics |
| Q36296695 | Cardiac Resynchronization Therapy Reduces Subcellular Heterogeneity of Ryanodine Receptors, T-Tubules, and Ca2+ Sparks Produced by Dyssynchronous Heart Failure |
| Q36311717 | Cardiac memory ... new insights into molecular mechanisms |
| Q36579498 | Cardiac resynchronisation therapy in heart failure: current status |
| Q42712619 | Cardiac resynchronization therapy and reverse molecular remodeling: importance of mitochondrial redox signaling |
| Q33964797 | Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure |
| Q90707081 | Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1β in heart failure |
| Q37140183 | Cardiac resynchronization: insight from experimental and computational models. |
| Q35898464 | Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacing-induced heart failure. |
| Q38644094 | Cellular and Molecular Aspects of Dyssynchrony and Resynchronization. |
| Q37965459 | Cellular electrophysiological abnormalities in dyssynchronous hearts and during CRT. |
| Q91588074 | Chronic Atrial and Ventricular Pacing in the Mouse |
| Q35778674 | Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study |
| Q47386580 | Dose-related ethanol intake, Cx43 and Nav1.5 remodeling: Exploring insights of altered ventricular conduction and QRS fragmentation in excessive alcohol users |
| Q34428553 | Dynamic dyssynchrony and impaired contractile reserve of the left ventricle in beta-thalassaemia major: an exercise echocardiographic study. |
| Q34017752 | Effect of nonuniform muscle contraction on sustainability and frequency of triggered arrhythmias in rat cardiac muscle. |
| Q30432167 | Electromechanical dyssynchrony and resynchronization of the failing heart |
| Q37245080 | Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy |
| Q51926557 | Gated blood pool tomoscintigraphy with 4-dimensional optical flow motion analysis quantifies left ventricular mechanical activation and synchronization. |
| Q38416938 | Gene therapy to restore electrophysiological function in heart failure |
| Q35822160 | Glycoproteins identified from heart failure and treatment models |
| Q35098555 | High resolution mapping of the cardiac transmural proteome using reverse phase protein microarrays |
| Q86783120 | Impacts of mitral E/e' on myocardial contractile motion and synchronicity in heart failure patients with reduced ejection fraction: An exercise-echocardiography study |
| Q37920404 | Implantable cardioverter defibrillators and cardiac resynchronisation therapy |
| Q38896453 | Improvement in left ventricular intrinsic dyssynchrony with cardiac resynchronization therapy. |
| Q48015814 | Intramolecular signaling in a cardiac connexin: Role of cytoplasmic domain dimerization. |
| Q50694931 | Intramural dyssynchrony and response to cardiac resynchronization therapy in patients with and without previous right ventricular pacing |
| Q85194554 | Is “Hyper Response” to Cardiac Resynchronization Therapy in Patients with Nonischemic Cardiomyopathy a Recovery, a Remission, or a Control? |
| Q36433578 | Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment |
| Q35968412 | Measuring mechanical function in the failing heart |
| Q46802997 | Measuring the metrics: Correlating t-tubule structure and muscle contraction in the intact heart |
| Q33771680 | Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy |
| Q27312512 | Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study |
| Q34207091 | Modulation of cardiac gap junction expression and arrhythmic susceptibility. |
| Q34066942 | Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts |
| Q30049005 | Multiple Reaction Monitoring to Identify Site-Specific Troponin I Phosphorylated Residues in the Failing Human Heart |
| Q84960298 | Optimal Left Ventricular Endocardial Pacing Sites for Cardiac Resynchronization Therapy in Patients With Ischemic Cardiomyopathy |
| Q37816282 | Past, present, and future of CRT. |
| Q35664494 | Pathobiology of cardiac dyssynchrony and resynchronization |
| Q36945236 | Physiology of biventricular pacing |
| Q35742264 | Physiology of cardiac resynchronization |
| Q50479657 | Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes. |
| Q57796295 | Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression |
| Q42579689 | Rethinking Resynch: Exploring Mechanisms of Cardiac Resynchroniztion Beyond Wall Motion Control |
| Q36174081 | Right ventricular outflow tract pacing: not ready for prime-time |
| Q44998997 | Risk stratification and prevention of sudden death in patients with heart failure |
| Q41172511 | Short-term effects of β2-AR blocker ICI 118,551 on sarcoplasmic reticulum SERCA2a and cardiac function of rats with heart failure |
| Q38212706 | Strategies to improve cardiac resynchronization therapy |
| Q33660591 | Structural and electrophysiological dysfunctions due to increased endoplasmic reticulum stress in a long-term pacing model using human induced pluripotent stem cell-derived ventricular cardiomyocytes |
| Q40538838 | Sudden death and its risk factors after atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation. |
| Q40544868 | The ethical challenges of animal research |
| Q55116460 | The interaction of QRS duration with cardiac magnetic resonance derived scar and mechanical dyssynchrony in systolic heart failure: Implications for cardiac resynchronization therapy. |
| Q37802796 | The molecular fingerprint of cardiac dyssynchrony and cardiac resynchronization therapy |
| Q64254231 | The value of left ventricular strain-volume loops in predicting response to cardiac resynchronization therapy |
| Q36873848 | The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heart |
| Q37154378 | Visualizing ion channel dynamics at the plasma membrane |
| Q80808974 | [Electrotherapy of cardiac failure] |
| Q80845295 | [His-bundle stimulation and alternative RV stimulation sites] |
| Q83239497 | [Is resynchronization therapy necessary when optimizing right ventricular stimulation?] |
| Q83239500 | [Upgrading to biventricular pacing: indications and procedural challenges] |
Search more.